* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
13 | Phosphorylation | SMGPELPTSPLAMEY CCCCCCCCCCCHHHH | 56.45 | 27732954 | |
14 | Phosphorylation | MGPELPTSPLAMEYV CCCCCCCCCCHHHHC | 18.90 | 25849741 | |
32 | Sumoylation | DLLKFDVKKEPLGRA HCEECCCCCCCCCCC | 53.95 | - | |
47 | Phosphorylation | ERPGRPCTRLQPAGS CCCCCCCCCCCCCCC | 36.78 | 22210691 | |
58 | Phosphorylation | PAGSVSSTPLSTPCS CCCCCCCCCCCCCCC | 22.27 | 22210691 | |
61 | Phosphorylation | SVSSTPLSTPCSSVP CCCCCCCCCCCCCCC | 31.35 | 27251275 | |
62 | Phosphorylation | VSSTPLSTPCSSVPS CCCCCCCCCCCCCCC | 35.68 | 27251275 | |
65 | Phosphorylation | TPLSTPCSSVPSSPS CCCCCCCCCCCCCCC | 35.26 | 27251275 | |
66 | Phosphorylation | PLSTPCSSVPSSPSF CCCCCCCCCCCCCCC | 44.77 | 27251275 | |
69 | Phosphorylation | TPCSSVPSSPSFSPT CCCCCCCCCCCCCCC | 53.37 | 24719451 | |
70 | Phosphorylation | PCSSVPSSPSFSPTE CCCCCCCCCCCCCCC | 20.63 | 28348404 | |
72 | Phosphorylation | SSVPSSPSFSPTEQK CCCCCCCCCCCCCCC | 40.06 | 27251275 | |
74 | Phosphorylation | VPSSPSFSPTEQKTH CCCCCCCCCCCCCHH | 34.94 | 27251275 | |
103 | Phosphorylation | NPEALNLTPEDAVEA CHHHHCCCHHHHHHH | 24.45 | - | |
251 | Phosphorylation | RTLKNRGYAQSCRYK HHHHHCHHHHHHHHH | 9.76 | 18083107 | |
270 | Ubiquitination | KHHLENEKTQLIQQV HHHHHHHHHHHHHHH | 53.83 | 29967540 | |
281 | Ubiquitination | IQQVEQLKQEVSRLA HHHHHHHHHHHHHHH | 44.07 | 29967540 | |
297 | Sumoylation | ERDAYKVKCEKLANS HHHHHHHHHHHHHHC | 32.31 | - | |
304 | Phosphorylation | KCEKLANSGFREAGS HHHHHHHCCCCCCCC | 33.43 | - | |
311 | Phosphorylation | SGFREAGSTSDSPSS CCCCCCCCCCCCCCC | 31.61 | 27251275 | |
312 | Phosphorylation | GFREAGSTSDSPSSP CCCCCCCCCCCCCCC | 35.32 | 23090842 | |
313 | Phosphorylation | FREAGSTSDSPSSPE CCCCCCCCCCCCCCC | 37.48 | 23090842 | |
315 | Phosphorylation | EAGSTSDSPSSPEFF CCCCCCCCCCCCCCC | 26.84 | 23090842 | |
317 | Phosphorylation | GSTSDSPSSPEFFL- CCCCCCCCCCCCCC- | 63.58 | 20363803 | |
318 | Phosphorylation | STSDSPSSPEFFL-- CCCCCCCCCCCCC-- | 31.65 | 20363803 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of MAFB_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference |
---|---|---|---|---|
32 | K | Sumoylation |
| - |
297 | K | Sumoylation |
| - |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of MAFB_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
MAFB_HUMAN | MAFB | physical | 15107855 | |
ZDHC2_HUMAN | ZDHHC2 | physical | 20211142 | |
ZF64A_HUMAN | ZFP64 | physical | 20211142 | |
ZF64B_HUMAN | ZFP64 | physical | 20211142 | |
MAFB_HUMAN | MAFB | physical | 16219768 | |
MAFB_HUMAN | MAFB | physical | 12196529 | |
IRF3_HUMAN | IRF3 | physical | 20581830 | |
IRF7_HUMAN | IRF7 | physical | 20581830 | |
IKKE_HUMAN | IKBKE | physical | 20581830 | |
BACH1_HUMAN | BACH1 | physical | 23661758 | |
MAFB_HUMAN | MAFB | physical | 23661758 | |
MAF_HUMAN | MAF | physical | 23661758 | |
ATF4_HUMAN | ATF4 | physical | 23661758 | |
FOSL1_HUMAN | FOSL1 | physical | 23661758 | |
FOS_HUMAN | FOS | physical | 23661758 | |
ZWINT_HUMAN | ZWINT | physical | 21988832 | |
NCOA6_HUMAN | NCOA6 | physical | 26180087 | |
KDM6A_HUMAN | KDM6A | physical | 26180087 | |
RBBP5_HUMAN | RBBP5 | physical | 26180087 | |
KAT2B_HUMAN | KAT2B | physical | 26180087 | |
PAX6_HUMAN | PAX6 | physical | 26180087 | |
ISL1_HUMAN | ISL1 | physical | 26180087 | |
MAFB_HUMAN | MAFB | physical | 12514174 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
166300 | Multicentric carpotarsal osteolysis syndrome (MCTO) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...